Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date.

Overview
Research
Identity
Additional Document Info
View All

authors

Hill, Lucas
Smith, Shawn R
Maile Young Karris, MD

publication date

January 1, 2018

published in

HIV/AIDS (Auckland, N.Z.) Journal